The main research interests of the group of Heymans focuses on heart failure with preserved ejection fraction (HFPEF) and dilated cardiomyopathies (DCM). He is the coordinator of the EarlyHFPEF programme since 2018, and involved as PI in the She-PREDICTS, DOUBLE DOSIS and ARENA PRIME projects. Prof. Heymans is acknowledged for developing a clinical care program and related cohorts of non-ischemic cardiomyopathies, myocarditis and HFPEF patients at the Maastricht UMC (> 1.400 patients cohort and biobank of HFPEF and DCM patients with > 12 yrs FU). His translational research program brings together immunologists, microbiologists, geneticists and molecular cardiologists to study the role of genetics, metabolism, inflammation and fibrosis and metabolism in DCM and HFPEF.
